COMMUNIQUÉS West-GlobeNewswire

Addex to Present at the 28th Medtech Investing Europe Conference
08/05/2019
Geneva, Switzerland, May 8, 2019 – Addex Therapeutics (SIX: ADXN), a leading company pioneering allosteric modulation-based drug discovery and development, announced today that CEO, Tim Dyer will give a corporate [...]
IBA Déclaration Intermédiaire – Premier Trimestre 2019
08/05/2019
Louvain-la-Neuve, Belgique, le 8 mai 2019 - IBA (Ion Beam Applications S.A.), le premier fournisseur mondial de solutions de protonthérapie pour le traitement du cancer, publie aujourd’hui une revue de ses activités au [...]
IBA BUSINESS UPDATE – FIRST QUARTER 2019
08/05/2019
Louvain-La-Neuve, Belgium, 8 May 2019 - IBA (Ion Beam Applications S.A., EURONEXT), the world’s leading provider of proton therapy solutions for the treatment of cancer, today announces its business update for the first [...]
MediciNova Participated in the RECEDE Phase 3 Degenerative Cervical Myelopathy Trial Kick-off Meeting, DCM Symposium and the Official Launch of Myelopathy.org in London, United Kingdom
08/05/2019
Dr. Yuichi Iwaki, M.D., Ph.D., President and Chief Executive Officer, invited speaker at the official launch of Myelopathy.org at The British Parliament House of Lords, shared his thoughts on supporting innovative [...]
TOWER ONE Cease Trade Order Due to Late Financial Statements
08/05/2019
VANCOUVER, British Columbia, May 07, 2019 (GLOBE NEWSWIRE) -- TOWER ONE WIRELESS CORP. (CSE: TO) (OTCQB: TOWTF) (Frankfurt: 1P3N) (“Tower One” or the “Company”) announces that a cease trade order has been issued against [...]
Veloxis Pharmaceuticals A/S Grants Warrants Under Existing Warrant Program
07/05/2019
Company Release no. 09/2019 To: NASDAQ Copenhagen A/S Copenhagen, Denmark, 07 May 2019 Veloxis Pharmaceuticals A/S Grants Warrants Under Existing Warrant Program Today, the Board of Directors of Veloxis Pharmaceuticals [...]
Aeterna Zentaris Reports First Quarter 2019 Financial and Operating Results
07/05/2019
CHARLESTON, S.C., May 07, 2019 (GLOBE NEWSWIRE) -- Aeterna Zentaris Inc. (NASDAQ: AEZS) (TSX: AEZS) today reported its financial and operating results for the first quarter ended March 31, 2019. All Amounts are in U.S. [...]
Supernus Announces First Quarter 2019 Financial Results
07/05/2019
Total revenue of $85.5 million and net product sales of $83.1 million. Net product sales compare to $89.1 million in 2018 and were adversely impacted by approximately $10 million in channel inventory reduction in the [...]
National Research Corporation Announces First Quarter 2019 Results
07/05/2019
LINCOLN, Neb., May 07, 2019 (GLOBE NEWSWIRE) -- National Research Corporation (NASDAQ: NRC) today announced results for the first quarter of 2019. Net New Sales of $4.1 million Net Income increased to $8.2 million 650+ [...]
Covetrus Reschedules First Quarter 2019 Earnings Release and Conference Call to May 15 and Files Historical Pro Forma 2018 Financial Information
07/05/2019
PORTLAND, Maine, May 07, 2019 (GLOBE NEWSWIRE) -- Covetrus, Inc. (Nasdaq: CVET) today announced that it has rescheduled the release of its first quarter 2019 earnings results and conference call to Wednesday, May 15, [...]
Atara Biotherapeutics to Announce First Quarter 2019 Financial Results and Host Conference Call on Thursday, May 9, 2019
07/05/2019
SOUTH SAN FRANCISCO, Calif., May 07, 2019 (GLOBE NEWSWIRE) -- Atara Biotherapeutics, Inc. (Nasdaq: ATRA), a leading off-the-shelf, allogeneic T-cell immunotherapy company developing novel treatments for patients with [...]
Eidos Therapeutics Reports First Quarter 2019 Financial Results
07/05/2019
SAN FRANCISCO, May 07, 2019 (GLOBE NEWSWIRE) -- Eidos Therapeutics, Inc. (Eidos) (Nasdaq:EIDX), today reported its financial results for the first quarter ended March 31, 2019 and provided an update on the company’s [...]
Foamix Reports First Quarter 2019 Financial Results and Provides Corporate Update
07/05/2019
FDA Accepts NDA for FMX101, Sets October 20, 2019 as PDUFA Action Date Conference Call Scheduled for Wednesday May 8 th at 8:30am Eastern Time REHOVOT, Israel and BRIDGEWATER, N.J., May 07, 2019 (GLOBE NEWSWIRE) -- [...]
OPKO Health Reports 2019 First Quarter Business Highlights and Financial Results
07/05/2019
Conference call begins today at 4:30 p.m. Eastern time MIAMI, May 07, 2019 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (NASDAQ: OPK) reports business highlights and financial results for the three months ended March 31, 2019 [...]
Inspire Medical Systems, Inc. Announces First Quarter 2019 Financial Results and Increases 2019 Outlook
07/05/2019
MINNEAPOLIS, May 07, 2019 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) ("Inspire"), a medical technology company focused on the development and commercialization of innovative and minimally invasive [...]
AnaptysBio Announces First Quarter 2019 Financial Results and Provides Pipeline Updates
07/05/2019
Multiple Top-line Phase 2 Clinical Efficacy Readouts from Wholly-owned Pipeline Anticipated in 2019 Etokimab Phase 2a Severe Eosinophilic Asthma Data to be Presented at the 2019 EAACI Congress IND Filing for New Wholly- [...]
Axovant Announces Reverse Share Split Effectiveness
07/05/2019
Shares to begin trading on split-adjusted basis on May 8, 2019 BASEL, Switzerland, May 07, 2019 (GLOBE NEWSWIRE) -- Axovant Gene Therapies Ltd. (Nasdaq: AXGT), a clinical-stage company developing innovative gene [...]
Progenics Pharmaceuticals Comments on Velan Capital’s Preliminary Proxy Statement
07/05/2019
No Shareholder Action Required at this Time NEW YORK, May 07, 2019 (GLOBE NEWSWIRE) -- Progenics Pharmaceuticals, Inc. (Nasdaq:PGNX, “Progenics” or the “Company”), an oncology company developing innovative targeted [...]
Novan to Present Clinical Data at Annual Meeting of the Society for Investigative Dermatology
07/05/2019
MORRISVILLE, N.C., May 07, 2019 (GLOBE NEWSWIRE) -- Novan, Inc. ("the Company" or "Novan") (NASDAQ:NOVN) today announced that recent data from the Company’s Phase 1b trial with SB414 cream for the treatment of atopic [...]

Pages